VMS BioMarketing Revenue and Competitors

Location

N/A

Total Funding

Marketing

Industry

Estimated Revenue & Valuation

  • VMS BioMarketing's estimated annual revenue is currently $60.2M per year.(i)
  • VMS BioMarketing's estimated revenue per employee is $275,000

Employee Data

  • VMS BioMarketing has 219 Employees.(i)
  • VMS BioMarketing grew their employee count by 10% last year.

VMS BioMarketing's People

NameTitleEmail/Phone
1
Principal OfficerReveal Email/Phone
2
Director Client SolutionsReveal Email/Phone
3
Executive Director, Client SolutionsReveal Email/Phone
4
Program ManagerReveal Email/Phone
5
National Clinical managerReveal Email/Phone
6
Non-Clinical Case ManagerReveal Email/Phone
7
Project ManagerReveal Email/Phone
8
Program ManagerReveal Email/Phone
9
Field Nurse EducatorReveal Email/Phone
10
Pharmaceutical Clinical Educator Nurse/NeuropsychiatryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.1M525%N/AN/A
#2
$2.9M1927%N/AN/A
#3
$0.1M1-75%N/AN/A
#4
$7M35N/AN/AN/A
#5
$6M30-12%N/AN/A
#6
$6.2M313%N/AN/A
#7
$51.4M187-9%N/AN/A
#8
$0.9M70%N/AN/A
#9
$1.7M11-79%N/AN/A
#10
$7M353%N/AN/A
Add Company

What Is VMS BioMarketing?

We empower patients to take control of their diagnosis, healthcare professionals to offer high caliber care, and brands to make it all happen. Brands partner with us to provide solutions that make complex therapies easier to understand and simpler to use. We work synergistically with clients to provide holistic patient support initiatives that result in real behavior change.

keywords:N/A

N/A

Total Funding

219

Number of Employees

$60.2M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

VMS BioMarketing News

2022-04-06 - Superior Patient Engagement – A “Must Have” For Biopharma

Andrea Heslin Smiley, President and CEO, VMS BioMarketing. Life sciences companies and their solution providers are partnering to reimagine the role patient...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$65M21918%N/A
#2
$61M22012%N/A
#3
$55.4M2226%N/A
#4
$35.6M223-45%N/A
#5
$45M224-20%N/A